GL1X · GenesisL1 explorer

Research workbench

SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor dFFR-yne

Analyse SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor dFFR-yne in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7MAU
Type
protein
Length
605 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.95
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
YVP, SO4
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · resolution 1.95 · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30526% helix, 29% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein30025% helix, 30% strandP0DTD1

Ligands and binding sites

  • YVP · N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-[(3S)-6-carbamimidamido-2-oxohexan-3-yl]-L-phenylalaninamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • DIO · 1,4-diethylene dioxide · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19690.760.7984SO4
22130.470.7530DIO, YVP
31970.460.7424YVP
4970.370.7522empty
51000.370.7524empty

Interfaces

1 interface between chains.

  • A–B · 1486 Ų buried · 34 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.